Tamoxifen improves cytopathic effect of oncolytic adenovirus in primary glioblastoma cells mediated through autophagy

Oncotarget
Ilya V UlasovCharles S Cobbs

Abstract

Oncolytic gene therapy using viral vectors may provide an attractive therapeutic option for malignant gliomas. These viral vectors are designed in a way to selectively target tumor cells and spare healthy cells. To determine the translational impact, it is imperative to assess the factors that interfere with the anti-glioma effects of the oncolytic adenoviral vectors. In the current study, we evaluated the efficacy of survivin-driven oncolytic adenoviruses pseudotyping with adenoviral fiber knob belonging to the adenoviral serotype 3, 11 and 35 in their ability to kill glioblastoma (GBM) cells selectively without affecting normal cells. Our results indicate that all recombinant vectors used in the study can effectively target GBM in vitro with high specificity, especially the 3 knob-modified vector. Using intracranial U87 and U251 GBM xenograft models we have also demonstrated that treatment with Conditionally Replicative Adenovirus (CRAd-S-5/3) vectors can effectively regress tumor. However, in several patient-derived GBM cell lines, cells exhibited resistance to the CRAd infection as evident from the diminishing effects of autophagy. To improve therapeutic response, tumor cells were pretreated with tamoxifen. Our preliminary ...Continue Reading

References

Apr 1, 1971·American Journal of Diseases of Children·D ManaloV N Mankad
Aug 14, 2003·Journal of Virology·Anna SegermanNiklas Arnberg
Jan 1, 1953·Cold Spring Harbor Symposia on Quantitative Biology·R DULBECCO, M VOGT
Apr 14, 2004·Journal of Virology·Dominique SirenaSilvio Hemmi
Sep 24, 2005·Cancer Biology & Therapy·Mariam A Stoff-KhaliliDavid T Curiel
Jan 18, 2006·Reviews in Medical Virology·Adam M SonabendMaciej S Lesniak
May 24, 2006·Human Gene Therapy·Ilya V UlasovMaciej S Lesniak
Aug 22, 2006·Virus Research·Joshua J ShortAlexander Pereboev
Mar 14, 2007·The Journal of Gene Medicine·Sophy ZhengMaciej S Lesniak
Jul 21, 2007·The Journal of Gene Medicine·Dennis HoffmannOliver Wildner
Aug 19, 2009·The Journal of Gene Medicine·Suvobroto NandiMaciej S Lesniak
Dec 25, 2009·Nature·Maria Stella CarroAntonio Iavarone
Dec 15, 2010·Nature Medicine·Hongjie WangAndré Lieber
Jun 2, 2011·Molecular Therapy : the Journal of the American Society of Gene Therapy·Atique U AhmedMaciej S Lesniak
Apr 10, 2012·European Journal of Pharmacology·Dimitry A Chistiakov, Vladimir P Chekhonin
Jul 13, 2012·Investigative Ophthalmology & Visual Science·Kyung Sook ChoJae-Young Koh
Sep 6, 2012·Neurochemistry International·Janka Held-FeindtSusanne Sebens
Nov 3, 2012·International Journal of Oncology·Xing LiHaibin Xia
Jul 3, 2013·EMBO Molecular Medicine·Florian A SiebzehnrublDennis A Steindler
Nov 22, 2013·The New England Journal of Medicine·Kristoffer HellstrandTomas Bergström
Jan 21, 2014·International Journal of Cancer. Journal International Du Cancer·Donatella VecchioGuido Frosina

❮ Previous
Next ❯

Citations

Jul 13, 2017·International Journal of Molecular Sciences·Hiroshi TazawaToshiyoshi Fujiwara
Aug 24, 2019·International Journal of Cancer. Journal International Du Cancer·Ilya V UlasovMaciej S Lesniak
Jan 21, 2021·International Journal of Molecular Sciences·Anastasia LaevskayaIlya Ulasov

❮ Previous
Next ❯

Methods Mentioned

BETA
PCR
xenografts

Software Mentioned

REMBRANDT
Prism GraphPad

Related Concepts

Related Feeds

Autophagy & Metabolism

Autophagy preserves the health of cells and tissues by replacing outdated and damaged cellular components with fresh ones. In starvation, it provides an internal source of nutrients for energy generation and, thus, survival. A powerful promoter of metabolic homeostasis at both the cellular and whole-animal level, autophagy prevents degenerative diseases. It does have a downside, however--cancer cells exploit it to survive in nutrient-poor tumors.

Autophagy & Model Organisms

Autophagy is a cellular process that allows degradation by the lysosome of cytoplasmic components such as proteins or organelles. Here is the latest research on autophagy & model organisms

Cancer Stem Cells in Glioblastoma

Glioblastoma is the most common and aggressive type of brain tumor. It contains a population of tumor initiating stem cell-like cells known as cancer stem cells. Investigations are ongoing into these cancer stem cells found in these solid tumors which are highly resistance to treatment. Here is the latest research on cancer stem cells in glioblastoma.

Autophagy & Disease

Autophagy is an important cellular process for normal physiology and both elevated and decreased levels of autophagy are associated with disease. Here is the latest research.

Parkinson's Disease & Autophagy (MDS)

Autophagy leads to degradation of damaged proteins and organelles by the lysosome. Impaired autophagy has been implicated in several diseases. Here is the role of autophagy in Parkinson’s disease.